fluoxetine and ALS - Amyotrophic Lateral Sclerosis

fluoxetine has been researched along with ALS - Amyotrophic Lateral Sclerosis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Heckman, CJ; Kajtaz, E; Kocevar, EJ; Koschnitzky, JE; Lukas, TJ; Mayers, WF; Quinlan, KA; Siddique, T	1
Aburakawa, Y; Aizawa, H; Hasebe, N; Kwak, S; Sawada, J; Yamashita, T	1
Dubois, B; Le Ber, I	1

Reviews

1 review(s) available for fluoxetine and ALS - Amyotrophic Lateral Sclerosis

Article	Year
[Frontotemporal dementia]. Presse medicale (Paris, France : 1983), 2007, Volume: 36, Issue:10 Pt 2 Topics: Adenosine Triphosphatases; Aged; Aged, 80 and over; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Aphasia, Primary Progressive; Brain; Cell Cycle Proteins; Dementia; Diagnosis, Differential; Fluoxetine; Frontal Lobe; Humans; Microtubule-Associated Proteins; Middle Aged; Parkinsonian Disorders; Selective Serotonin Reuptake Inhibitors; Temporal Lobe; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Trazodone; Valosin Containing Protein	2007

Article

Year

[Frontotemporal dementia].

Presse medicale (Paris, France : 1983), 2007, Volume: 36, Issue:10 Pt 2

Topics: Adenosine Triphosphatases; Aged; Aged, 80 and over; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Aphasia, Primary Progressive; Brain; Cell Cycle Proteins; Dementia; Diagnosis, Differential; Fluoxetine; Frontal Lobe; Humans; Microtubule-Associated Proteins; Middle Aged; Parkinsonian Disorders; Selective Serotonin Reuptake Inhibitors; Temporal Lobe; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Trazodone; Valosin Containing Protein

2007

Other Studies

2 other study(ies) available for fluoxetine and ALS - Amyotrophic Lateral Sclerosis

Article	Year
Effect of fluoxetine on disease progression in a mouse model of ALS. Journal of neurophysiology, 2014, Jun-01, Volume: 111, Issue:11 Topics: Amyotrophic Lateral Sclerosis; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Fluoxetine; Longitudinal Studies; Mice; Mice, Transgenic; Rotarod Performance Test; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Tremor	2014
Effects of antidepressants on GluR2 Q/R site-RNA editing in modified HeLa cell line. Neuroscience research, 2009, Volume: 64, Issue:3 Topics: Adenosine Deaminase; Amitriptyline; Amyotrophic Lateral Sclerosis; Antidepressive Agents; Arginine; Cyclopropanes; Desipramine; Fluoxetine; Fluvoxamine; Glutamine; HeLa Cells; Humans; Imipramine; Milnacipran; Morpholines; Paroxetine; Reboxetine; Receptors, AMPA; RNA Editing; RNA-Binding Proteins; RNA, Messenger	2009

Article

Year

Effect of fluoxetine on disease progression in a mouse model of ALS.

Journal of neurophysiology, 2014, Jun-01, Volume: 111, Issue:11

Topics: Amyotrophic Lateral Sclerosis; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Fluoxetine; Longitudinal Studies; Mice; Mice, Transgenic; Rotarod Performance Test; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Tremor

2014

Effects of antidepressants on GluR2 Q/R site-RNA editing in modified HeLa cell line.

Neuroscience research, 2009, Volume: 64, Issue:3

Topics: Adenosine Deaminase; Amitriptyline; Amyotrophic Lateral Sclerosis; Antidepressive Agents; Arginine; Cyclopropanes; Desipramine; Fluoxetine; Fluvoxamine; Glutamine; HeLa Cells; Humans; Imipramine; Milnacipran; Morpholines; Paroxetine; Reboxetine; Receptors, AMPA; RNA Editing; RNA-Binding Proteins; RNA, Messenger

2009